|
|
1.
|
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. MedStar authors:
Year: 2023
Citation: - Transfusion. 63(9):1639-1648, 2023 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Huaman MA, Raval JS, Paxton JH, Mosnaim GS, Patel B, Anjan S, Meisenberg BR, Levine AC, Marshall CE, Yarava A, Shenoy AG, Heath SL, Currier JS, Fukuta Y, Blair JE, Spivak ES, Petrini JR, Broderick PB, Rausch W, Cordisco M, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Kassaye SG, Ram M, Wang Y, Das P, Lane K, McBee NA, Gawad AL, Karlen N, Ford DE, Laeyendecker O, Pekosz A, Klein SL, Ehrhardt S, Lau B, Baksh SN, Shade DM, Casadevall A, Hanley DF, Ou J, Gniadek TJ, Ziman A, Shoham S, Gebo KA, Bloch EM, Tobian AAR, Sullivan DJ, Gerber JM
|
|
|
2.
|
Early mortality benefit with COVID-19 convalescent plasma: a matched control study. MedStar authors:
- Baez, Valentina
- Blumenthal, Joseph
- Fernandez, Stephen J
- Hettinger, Aaron Z
- Shenoy, Aarthi G
Year: 2021
Citation: - British Journal of Haematology. 192(4):706-713, 2021 02.
Institution:
- MedStar Harbor Hospital
- MedStar Heart & Vascular Institute
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Emergency Medicine
- Medicine
Medline publication type:
All authors: - Baez V, Blumenthal J, Fernandez SJ, Hettinger AZ, Shenoy AG
|
